REGENXBIO Announces Presentations at the 19th Annual WORLDSy

/PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that three oral and eight poster presentations will be presented at the 19th Annual...

Related Keywords

Eppendorf , Nordrhein Westfalen , Germany , Hamburg , Rockville , California , United States , Philadelphia , Pennsylvania , Florida , University Of Pennsylvania , Orlando , Irvine , Christina Ohnsman , Raymond Wang , Chris Brinzey , Kwi Hye Kim , Keigo Takahashi , Yoonjin Cho , Dana Cormack , Gary Chan , Luca Hagenah , University Of California , Clinical Outcomes Research , Technology Platform , Technology Platform Licensees , University Medical Center Hamburg , Nasdaq , Pediatric Storage Disease Lab , Preclinical Development , Metabolic Disease Program Children Hospital Of Philadelphia , Division Of Metabolic Disorders , Newborn Metabolic Screening Program , Corporate Communications , Senior Clinical Development , Department Of Pediatrics , Washington University In St , Lysosomal Storage Diseases Program , Overview Of Nonclinical Development Program , Hunter Syndrome , Potential Treatment Modality , Metabolic Disorders , Principal Scientist , Can Ficicioglu , Perelman School , Clinical Director , Metabolic Disease Program Children , Poster Wednesday , Washington University , Ocular Manifestations , Nonclinical Development Program , University Medical Center Hamburg Eppendorf , Vineland Adaptive Behavioral Scale Version , Mucopolysaccharidosis Type , Senior Director , Senior Clinical Development Lead , Platform Licensees , Regenxbio Inc , Biotechnology , Health Care Amp Hospitals , Medical Pharmaceuticals , Clinical Trials Amp Medical Discoveries ,